2024 Q4 Form 10-Q Financial Statement

#000089710124000563 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $14.67M
YoY Change 19.02%
Cost Of Revenue $3.177M
YoY Change 12.42%
Gross Profit $11.49M
YoY Change 20.98%
Gross Profit Margin 78.34%
Selling, General & Admin $9.387M
YoY Change 2.59%
% of Gross Profit 81.69%
Research & Development $166.0K
YoY Change -19.42%
% of Gross Profit 1.44%
Depreciation & Amortization $202.0K
YoY Change 0.0%
% of Gross Profit 1.76%
Operating Expenses $9.553M
YoY Change 2.11%
Operating Profit $1.938M
YoY Change 1264.79%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.133M
YoY Change 873.97%
Income Tax $659.0K
% Of Pretax Income 30.9%
Net Earnings $1.474M
YoY Change 850.97%
Net Earnings / Revenue 10.05%
Basic Earnings Per Share $0.17
Diluted Earnings Per Share $0.16
COMMON SHARES
Basic Shares Outstanding 8.458M shares 8.639M shares
Diluted Shares Outstanding 8.981M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $13.86M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $3.434M
Prepaid Expenses
Receivables $22.37M
Other Receivables
Total Short-Term Assets $41.01M
YoY Change 13.3%
LONG-TERM ASSETS
Property, Plant & Equipment $5.003M
YoY Change -9.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $90.00K
YoY Change -37.06%
Total Long-Term Assets $7.905M
YoY Change 0.43%
TOTAL ASSETS
Total Short-Term Assets $41.01M
Total Long-Term Assets $7.905M
Total Assets $48.92M
YoY Change 11.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.784M
YoY Change 68.78%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.419M
YoY Change 28.45%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.419M
Total Long-Term Liabilities
Total Liabilities $7.427M
YoY Change 27.09%
SHAREHOLDERS EQUITY
Retained Earnings $20.59M
YoY Change 8.65%
Common Stock $85.00K
YoY Change -1.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.49M
YoY Change
Total Liabilities & Shareholders Equity $48.92M
YoY Change 11.0%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $1.474M
YoY Change 850.97%
Depreciation, Depletion And Amortization $202.0K
YoY Change 0.0%
Cash From Operating Activities $2.309M
YoY Change -1046.31%
INVESTING ACTIVITIES
Capital Expenditures $37.00K
YoY Change -66.06%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$58.00K
YoY Change -56.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$4.467M
YoY Change -15503.45%
NET CHANGE
Cash From Operating Activities $2.309M
Cash From Investing Activities -$58.00K
Cash From Financing Activities -$4.467M
Net Change In Cash -$2.216M
YoY Change 536.78%
FREE CASH FLOW
Cash From Operating Activities $2.309M
Capital Expenditures $37.00K
Free Cash Flow $2.272M
YoY Change -743.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001488917
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
001-34839
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Electromed, Inc.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1732920
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
New Prague
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
56071
CY2024Q3 dei City Area Code
CityAreaCode
(952)
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
758-9299
CY2023Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
usd
CY2023Q3 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
usd
CY2024Q3 elmd Demonstration Equipment Returned To Inventory
DemonstrationEquipmentReturnedToInventory
usd
CY2023Q3 elmd Taxes Owed On Net Share Settlement Of Stock Awards In Accrued Liabilities
TaxesOwedOnNetShareSettlementOfStockAwardsInAccruedLiabilities
usd
CY2023Q3 elmd Issuance Of Common Stock Upon Vesting Of Performancebased Stock Units
IssuanceOfCommonStockUponVestingOfPerformancebasedStockUnits
usd
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
487000 usd
CY2024Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
usd
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
500 Sixth Avenue NW
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8458005 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13864000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16080000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22366000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23333000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
754000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
719000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3434000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3712000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
592000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
329000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
41010000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
44173000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5003000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5165000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
660000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
657000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
90000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
87000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2152000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2152000 usd
CY2024Q3 us-gaap Assets
Assets
48915000 usd
CY2024Q2 us-gaap Assets
Assets
52234000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1784000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1010000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2150000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3893000 usd
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
188000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
277000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1641000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1567000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1656000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
930000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7419000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7677000 usd
CY2024Q3 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
8000 usd
CY2024Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
12000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
7427000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
7689000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
13000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8457071 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8457071 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8637883 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8637883 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
85000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
87000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20816000 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20790000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
20587000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23668000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
41488000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
44545000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48915000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52234000 usd
CY2024Q3 us-gaap Revenues
Revenues
14668000 usd
CY2023Q3 us-gaap Revenues
Revenues
12324000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
3177000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
2826000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
11491000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
9498000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9387000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9150000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
166000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
206000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
9553000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
9356000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1938000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
142000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
195000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
77000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2133000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
219000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
659000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
155000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8564489 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8537388 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8980714 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8782824 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
155000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
202000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
202000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12000 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
697000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
371000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-967000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-675000 usd
CY2024Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
35000 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
57000 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-278000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
240000 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
266000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-901000 usd
CY2024Q3 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-89000 usd
CY2023Q3 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-226000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
806000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-863000 usd
CY2024Q3 elmd Accrued Compensation
AccruedCompensation
1743000 usd
CY2023Q3 elmd Accrued Compensation
AccruedCompensation
1174000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2309000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-244000 usd
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
109000 usd
CY2024Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
21000 usd
CY2023Q3 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
24000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-133000 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
84000 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
29000 usd
CY2024Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
15000 usd
CY2024Q3 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
4536000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4467000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2216000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-348000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16080000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7372000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13864000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7024000 usd
CY2024Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
752000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
251000 usd
CY2024Q3 elmd Property And Equipment Acquisitions In Accounts Payable
PropertyAndEquipmentAcquisitionsInAccountsPayable
7000 usd
CY2023Q3 elmd Property And Equipment Acquisitions In Accounts Payable
PropertyAndEquipmentAcquisitionsInAccountsPayable
34000 usd
CY2023Q3 elmd Demonstration Equipment Returned To Inventory
DemonstrationEquipmentReturnedToInventory
19000 usd
CY2024Q3 elmd Taxes Owed On Net Share Settlement Of Stock Awards In Accrued Liabilities
TaxesOwedOnNetShareSettlementOfStockAwardsInAccruedLiabilities
740000 usd
CY2024Q3 elmd Issuance Of Common Stock Upon Vesting Of Performancebased Stock Units
IssuanceOfCommonStockUponVestingOfPerformancebasedStockUnits
1000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
37667000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
155000 usd
CY2023Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
29000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
371000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
38222000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
44545000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2024Q3 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-670000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
697000 usd
CY2024Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4558000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
41488000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14668000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12324000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
22366000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23333000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
754000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
719000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
719000 usd
CY2024Q3 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-638000 usd
CY2024 us-gaap Contract With Customer Asset Reclassified To Receivable
ContractWithCustomerAssetReclassifiedToReceivable
-2325000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
689000 usd
CY2024 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2840000 usd
CY2024Q3 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-16000 usd
CY2024 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice
-283000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
754000 usd
CY2024Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
719000 usd
CY2024Q3 us-gaap Other Inventory Supplies
OtherInventorySupplies
1978000 usd
CY2024Q2 us-gaap Other Inventory Supplies
OtherInventorySupplies
2556000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
390000 usd
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
454000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
939000 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
834000 usd
CY2024Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
358000 usd
CY2024Q2 us-gaap Other Inventory In Transit
OtherInventoryInTransit
265000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
231000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
397000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3434000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3712000 usd
CY2024Q3 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
494000 usd
CY2024Q2 us-gaap Accrued Insurance Current And Noncurrent
AccruedInsuranceCurrentAndNoncurrent
467000 usd
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
766000 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
396000 usd
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
463000 usd
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1656000 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
930000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1567000 usd
CY2023Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1378000 usd
CY2024Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
170000 usd
CY2024 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
559000 usd
CY2024Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
96000 usd
CY2024 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
370000 usd
CY2024Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1641000 usd
CY2024Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1567000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
659000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.309 pure
CY2024Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.293 pure
CY2024Q3 elmd Debt Instrument Covenant Compliance Amount
DebtInstrumentCovenantComplianceAmount
10125000 usd
CY2024Q3 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
4536000 usd
CY2024Q3 us-gaap Share Price
SharePrice
17.26
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
697000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
371000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0369 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0385 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0464 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.53 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.51 pure
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.52 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
678856 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
1474000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
155000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8564489 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8537388 shares
CY2024Q3 elmd Effect Of Dilutive Common Stock Equivalents
EffectOfDilutiveCommonStockEquivalents
416225 shares
CY2023Q3 elmd Effect Of Dilutive Common Stock Equivalents
EffectOfDilutiveCommonStockEquivalents
245436 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8980714 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8782824 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2024Q3 elmd Common Stock Equivalents
CommonStockEquivalents
44026 shares
CY2023Q3 elmd Common Stock Equivalents
CommonStockEquivalents
403944 shares
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000897101-24-000563-index-headers.html Edgar Link pending
0000897101-24-000563-index.html Edgar Link pending
0000897101-24-000563.txt Edgar Link pending
0000897101-24-000563-xbrl.zip Edgar Link pending
elmd-20240930.xsd Edgar Link pending
elmd241174_10q.htm Edgar Link pending
elmd241174_ex10-1.htm Edgar Link pending
elmd241174_ex10-2.htm Edgar Link pending
elmd241174_ex31-1.htm Edgar Link pending
elmd241174_ex31-2.htm Edgar Link pending
elmd241174_ex32-1.htm Edgar Link pending
elmd-20240930_def.xml Edgar Link unprocessable
elmd-20240930_cal.xml Edgar Link unprocessable
elmd-20240930_lab.xml Edgar Link unprocessable
elmd-20240930_pre.xml Edgar Link unprocessable
elmd241174_10q_htm.xml Edgar Link completed
elmd241174_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending